INO News and Press, Inovio Pharmaceuticals Inc.

2024-07-16 13:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Inseego Corp. (Nasdaq: INSG), a technology leader in 5G mobile and fixed wireless solutions for mobile network operators, Fortune 500 enterprises and SMBs, today announced that the company will release its financial results for the second quarter of 2024, ended June 30, 2024, after the financial ...

2024-07-12 15:15:55 ET Summary This edition of the 'Undercovered' Dozen highlights twelve ideas from June 28th - July 11th on stocks with limited coverage. Navitas Semiconductor is seen as facing risks in the AI data center market, but could benefit from chip proliferation. Ch...

INO-3107 Awarded the Innovation Passport Designation Under U.K. Government's Innovative Licensing and Access Pathway PR Newswire Award recognizes the potential for INO-3107 to be the first therapeutic option in the United Kingdom for patients suffering from Recurrent Respi...

2024-07-08 04:00:08 ET Summary Inovio is on track for filing its BLA for INO-3107 in the latter half of 2024. INO-3107 has little in the way of pipeline support. Expect significant dilution as Inovio proceeds with its BLA and anticipated approval and launch of INO-3107. ...

INOVIO Announces Appointment of Steven Egge as Chief Commercial Officer PR Newswire Mr. Egge brings over 25 years of biopharmaceutical experience building commercial organizations and successfully launching novel therapeutic products INOVIO poised to become a commercia...

2024-07-01 08:22:25 ET More on Inovio Pharmaceuticals Inovio Pharmaceuticals, Inc. (INO) The Citizens JMP Life Sciences Conference (Transcript) Inovio Pharmaceuticals GAAP EPS of -$1.31 misses by $0.31 Inovio Pharmaceuticals Q1 2024 Earnings Preview Read th...

INOVIO Added to Russell 2000® Index Effective July 1, 2024 PR Newswire PLYMOUTH MEETING, Pa. , July 1, 2024 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect p...

Company executes capital structure management initiative to reduce total debt by purchasing for cash and exchanging for long-term debt and equity, $125 million of face value, or nearly 80% of outstanding convertible notes, at 30% discount Inseego Corp. (Nasdaq: INSG) (the “Compan...

INOVIO to Participate in Virtual Fireside Chat Hosted by Stephens Inc. PR Newswire PLYMOUTH MEETING, Pa. , June 4, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and pro...